Clinical guidelines

The National Health and Medical Research Council Clinical Guidelines provide an evidence base for the National Bowel Cancer Screening Program.

Page last updated: 14 April 2017

The National Health and Medical Research Council Clinical Guidelines for Prevention, Early Detection and Management of Colorectal Cancer(2005) have been rescinded by the NHMRC, in accordance with standard practice for publications that are more than five years old, as the guidelines may no longer represent best practice. The guidelines are currently under review and it is anticipated that revised guidelines will be published in late October 2017.

The Clinical practice guidelines for the prevention, early detection and management of colorectal cancer: A guide for General Practitioners provides a summary of the main evidence based recommendations from the 2005 guidelines.

The 2011Clinical Practice Guidelines for Surveillance Colonoscopy focus on the appropriate use of colonoscopy in colorectal cancer prevention and are also under review, it is anticipated that the revised guidelines will be published in 2018.

Other guidelines, policies and evidence reviews

The Royal Australian College of General Practitioners’ Guidelines for preventive activities in general practice provides guidance on bowel cancer screening.

The Cancer Council Australia’s National Cancer Control Policy: Bowel Screening provides evidence on why the FOBT is the recommended screening tool for bowel cancer.

HealthPACT report - Blood and stool biomarker testing for colorectal cancer screening - August 2016 - an assessment which compared the FOBT used in the Australian NBCSP with other blood-based biomarker and stool-based tests for the detection of colorectal cancer. There is a lack of evidence to support the use of these tests to detect early adenomas.

In this section